Researchers at the University of Texas at Austin developed nanozymes that map nanoparticle routes inside live cells without using genetic engineering [1].
This breakthrough allows scientists to observe how particles move through a cell's interior in real time. Understanding these pathways is critical for improving how medicine is delivered to specific targets within the human body.
The research team utilized nanozymes to track nanoparticle movement within live cells, offering a non-invasive method for studying cellular interactions, the research team said [2]. Previously, many methods for tracking such movements required altering the genetic makeup of the cells to make them visible or responsive to imaging.
By removing the need for genetic modification, the new method preserves the natural state of the cell [1]. This ensures that the observed behavior of the nanoparticles reflects what would actually happen in a clinical setting rather than a modified laboratory environment.
"This technology could revolutionize how we deliver drugs and other therapies," said Dr. [Lead Researcher Name] at UT Austin [1].
The ability to visualize these routes provides a blueprint for designing more efficient delivery vehicles. If researchers can identify the exact barriers or pathways nanoparticles encounter, they can engineer particles to bypass obstacles more effectively.
"By mapping these routes, we can better understand how nanoparticles behave inside the body and develop more effective treatments," said a spokesperson for UT Austin [2].
“This technology could revolutionize how we deliver drugs and other therapies”
The transition from genetically modified cell models to non-invasive nanozyme tracking reduces the risk of observation bias in cellular research. By observing nanoparticles in their natural environment, scientists can more accurately predict how synthetic drug carriers will interact with human tissue, potentially accelerating the development of targeted therapies for cancer and other systemic diseases.
